Article
NovumRNA: accurate prediction of non-canonical tumor antigens from RNA sequencing data
2024-11-08
Abstract excerpt
<h4>Summary</h4> Non-canonical tumor-specific antigens (ncTSAs) can expand the pool of targets for cancer immunotherapy, but require robust and comprehensive computational pipelines for their prediction. Here, we present NovumRNA, a fully-automated Nextflow pipeline for predicting different classes of ncTSAs from patients’ RNA sequencing data. We extensively validated NovumRNA using publicly-available and newly-g...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c9375013-1381-508d-b67a-edf9160804ce
- DOI
- 10.1101/2024.11.05.622043
